MGF

Research

Mechano Growth Factor (IGF-1Ec)

Category
Growth Hormone
Aliases
IGF-1Ec, IGF-1 splice variant
Administration
Subcutaneous/intramuscular injection near target muscle (research)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Effects are intended to be highly localized and short-lived, given the compound's instability, rather than felt over a multi-week arc.

  2. 2

    3–4 Weeks

    Any felt effect would typically relate to the specific muscle worked or injured, not a whole-body sensation.

  3. 3

    5–7 Weeks

    Limited human data makes a longer-term felt timeline difficult to characterize.

  4. 4

    8–10 Weeks

    No established human timeline exists for continued or cumulative effects.

  5. 5

    11–15 Weeks

    Available evidence does not describe outcomes at this duration.

  6. 6

    16–20 Weeks

    Not well characterized in available research.

  7. 7

    21–24 Weeks

    Users considering long-term use should note the lack of established human data at this duration.

⚠️ Research context only. This is not medical advice and results are not guaranteed.